LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 85

Search options

  1. Article ; Online: Chronic rhinosinusitis, nasal polyposis and asthma: the united airways concept reconsidered?

    Braunstahl, G-J

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

    2011  Volume 41, Issue 10, Page(s) 1341–1343

    MeSH term(s) Asthma/immunology ; Asthma/physiopathology ; Bronchi/physiopathology ; Female ; Humans ; Male ; Nasal Polyps/physiopathology ; Rhinitis/physiopathology ; Sinusitis/physiopathology
    Language English
    Publishing date 2011-10
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 645204-8
    ISSN 1365-2222 ; 0954-7894 ; 0960-2178
    ISSN (online) 1365-2222
    ISSN 0954-7894 ; 0960-2178
    DOI 10.1111/j.1365-2222.2011.03796.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The united airways concept

    G.J. Braunstahl

    Monaldi Archives for Chest Disease, Vol 67, Iss

    from bench to bedside

    2016  Volume 2

    Abstract: ...

    Abstract -
    Keywords Medicine ; R
    Language English
    Publishing date 2016-02-01T00:00:00Z
    Publisher PAGEPress Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: The Fractional exhaled Nitric Oxide (FeNO)- test as add-on test in the diagnostic work-up of asthma: a study protocol.

    Kaya, T Tuba / Braunstahl, G J Gert-Jan / Veen, J C C M Johannes In 't / Kappen, J H Jasper / Valk, J P M Hanna van der

    BMC pulmonary medicine

    2024  Volume 24, Issue 1, Page(s) 178

    Abstract: Background: Asthma is a common disease characterized by chronic inflammation of the lower airways, bronchial hyperactivity, and (reversible) airway obstruction. The Global Initiative of Asthma Guideline recommends a flowchart to diagnose asthma with ... ...

    Abstract Background: Asthma is a common disease characterized by chronic inflammation of the lower airways, bronchial hyperactivity, and (reversible) airway obstruction. The Global Initiative of Asthma Guideline recommends a flowchart to diagnose asthma with first-step spirometry with reversibility and a bronchial challenge test (BPT) with histamine or methacholine as a second step [1]. The BPT is considered burdensome, time-consuming for patients and staff, can cause side effects, and is expensive. In addition, this test strongly encumbers lung function capacity. Elevated Nitric Oxide (NO) is associated with airway eosinophilic inflammation in asthma patients and can be measured in exhaled air with the Fractional exhaled (Fe) NO-test. This low-burden FeNO-test could be used as an 'add-on' test in asthma diagnostics [2, 3].
    Methods and analysis: This multi-center prospective study (Trial number: NCT06230458) compares the 'standard asthma diagnostic work-up' (spirometry with reversibility and BPT) to the 'new asthma diagnostics work-up' (FeNO-test as an intermediate step between the spirometry with reversibility and the BPT), intending to determine the impact of the FeNO-based strategy, in terms of the number of avoided BPTs, cost-effectiveness and reduced burden to the patient and health care. The cost reduction of incorporating the FeNO-test in the new diagnostic algorithm will be established by the number of theoretically avoided BPT. The decrease in burden will be studied by calculating differences in the Visual Analogue Scale (VAS) -score and Asthma Quality of Life Questionnaire (AQLQ) -score after the BPT and FeNO-test with an independent T-test. The accuracy of the FeNO-test will be calculated by comparing the FeNO-test outcomes to the (gold standard) BPTs outcomes in terms of sensitivity and specificity. The intention is to include 171 patients.
    Ethics and dissemination: The local medical ethics committee approved the proposed study and is considered a low-burden and risk-low study. The local medical ethics committee registration number: R23.005.
    Strengths and limitations of this study: Strengths: This is the first study that investigates the value of the FeNO-test (cut off ≥ 50 ppb) as an add-on test, to determine the impact of the FeNO-based strategy, in terms of the number of avoided BPTs, cost-effectiveness, and reduced burden on the patient and health care.
    Limitations: High FeNO levels may also be observed in other diseases such as eosinophilic chronic bronchitis and allergic rhinitis. The FeNO-test can be used to rule in a diagnosis of asthma with confidence, however, due to the poor sensitivity it is not suitable to rule out asthma.
    MeSH term(s) Humans ; Fractional Exhaled Nitric Oxide Testing ; Prospective Studies ; Quality of Life ; Breath Tests ; Asthma/drug therapy ; Nitric Oxide ; Bronchitis, Chronic ; Inflammation ; Multicenter Studies as Topic
    Chemical Substances Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2024-04-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2059871-3
    ISSN 1471-2466 ; 1471-2466
    ISSN (online) 1471-2466
    ISSN 1471-2466
    DOI 10.1186/s12890-024-02990-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Patients' evaluation of aftercare following hospitalization for COVID-19: satisfaction and unmet needs.

    Berentschot, Julia C / de Ridder, Willemijn A / Bek, L Martine / Heijenbrok-Kal, Majanka H / Braunstahl, Gert-Jan / Remerie, Sylvia C / Stuip, Yvonne / Ribbers, Gerard M / Aerts, Joachim G J V / Ista, Erwin / Hellemons, Merel E / van den Berg-Emons, Rita J G

    Respiratory research

    2024  Volume 25, Issue 1, Page(s) 145

    Abstract: Background: Patient experiences with COVID-19 aftercare remain largely unknown. We evaluated COVID-19 aftercare from a patient perspective one year after hospitalization, assessing satisfaction and its associated factors, and unmet needs.: Methods: ... ...

    Abstract Background: Patient experiences with COVID-19 aftercare remain largely unknown. We evaluated COVID-19 aftercare from a patient perspective one year after hospitalization, assessing satisfaction and its associated factors, and unmet needs.
    Methods: The Satisfaction with COVID-19 Aftercare Questionnaire (SCAQ) was developed as part of a multicenter prospective cohort study and administered one year after hospital discharge. The SCAQ assesses (1) patient satisfaction, comprising information provision, rehabilitation, follow-up by hospitals and general practitioners (GPs), the most important aftercare topics, and overall satisfaction, and (2) unmet needs.
    Results: 487/561 (87%) COVID-19 patients completed the SCAQ, all had been discharged from the hospital between March 2020 and May 2021. Among responders, the median age of patients was 60 (IQR 54-67) years, 338 (69%) were male, and the median length of stay in the hospital was 13 (6-27) days. Patients were least satisfied with information on who could be contacted with questions when health problems arise (59% satisfied or very satisfied). Many patients (75%) received rehabilitation, most frequently community-based (70%). Across the different community-based therapies, ≥ 60% of patients were satisfied with shared-decision making and ≥ 70% with the received therapy; a majority (≥ 79%) indicated a preference for receiving the same therapy again if needed. Regarding follow-up by hospitals, 86% of patients received this follow-up, most frequently visiting a pulmonologist (96%), being generally satisfied with the received aftercare. Aftercare from GPs was received by 39% of patients, with 88% being satisfied with the GP's availability and 79% with referral to appropriate aftercare providers. Patients (> 50%) considered information-related items most important in aftercare. Overall, patients rated their satisfaction with aftercare 8/10 (7-9) points. Those who received medical rehabilitation (versus no rehabilitation, adjusted beta 0.61 [95%CI 0.11 to 1.11], p = 0.02) or aftercare by a hospital medical specialist (1.1 [0.46 to 1.64], p < 0.001) or GP (0.39 [0.053 to 0.72], p = 0.023) reported significantly higher satisfaction than those without such aftercare. Unmet needs were reported by 35% of patients, with lack of information (20%) and lack of additional aftercare and/or involvement of their GP (19%) being the most frequently reported.
    Conclusion: Despite the forced quick development of COVID-19 aftercare, patients were generally satisfied. Follow-up by healthcare professionals and information provision is important to meet patients' aftercare needs.
    MeSH term(s) Female ; Humans ; Male ; Aftercare ; COVID-19/therapy ; Hospitalization ; Patient Satisfaction ; Prospective Studies ; Middle Aged ; Aged
    Language English
    Publishing date 2024-03-29
    Publishing country England
    Document type Multicenter Study ; Journal Article
    ZDB-ID 2041675-1
    ISSN 1465-993X ; 1465-993X
    ISSN (online) 1465-993X
    ISSN 1465-993X
    DOI 10.1186/s12931-024-02748-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: ERS International Congress 2023: highlights from the Airway Diseases Assembly.

    Bergantini, Laura / Baker, James / Bossios, Apostolos / Braunstahl, Gert-Jan / Conemans, Lennart H / Lombardi, Francesco / Mathioudakis, Alexander G / Pobeha, Pavol / Ricciardolo, Fabio Luigi Massimo / Prada Romero, Leidy Paola / Schleich, Florence / Snelgrove, Robert J / Trinkmann, Frederik / Uller, Lena / Beech, Augusta

    ERJ open research

    2024  Volume 10, Issue 2

    Abstract: In this review, early career and senior members of Assembly 5 (Airway Diseases, Asthma, COPD and Chronic Cough) present key recent findings pertinent to airway diseases that were presented during the European Respiratory Society International Congress ... ...

    Abstract In this review, early career and senior members of Assembly 5 (Airway Diseases, Asthma, COPD and Chronic Cough) present key recent findings pertinent to airway diseases that were presented during the European Respiratory Society International Congress 2023 in Milan, Italy, with a particular focus on asthma, COPD, chronic cough and bronchiectasis. During the congress, an increased number of symposia, workshops and abstract presentations were organised. In total, 739 abstracts were submitted for Assembly 5 and the majority of these were presented by early career members. These data highlight the increased interest in this group of respiratory diseases.
    Language English
    Publishing date 2024-03-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00891-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Visceral adipose tissue: A relevant inflammatory compartment in obesity-related asthma?

    Türk, Y / Witte, J A / van Huisstede, A / Melgert, B N / van Schadewijk, A / Taube, C / Hiemstra, P S / Kappen, J H / Braunstahl, G J

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

    2023  Volume 53, Issue 12, Page(s) 1295–1297

    MeSH term(s) Humans ; Obesity/complications ; Adipose Tissue ; Asthma/etiology
    Language English
    Publishing date 2023-09-26
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 645204-8
    ISSN 1365-2222 ; 0954-7894 ; 0960-2178
    ISSN (online) 1365-2222
    ISSN 0954-7894 ; 0960-2178
    DOI 10.1111/cea.14395
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.

    Bendien, S A / van Leeuwen, M M / Lau, H S / Ten Brinke, A / Visser, L E / de Koning, E M / Braunstahl, G J

    Respiratory medicine

    2022  Volume 194, Page(s) 106776

    Abstract: The anti-IL-5 biologic reslizumab for the treatment of severe eosinophilic asthma is administered intravenously. In the current study home administration of intravenous reslizumab was evaluated in 24 patients included between 2019 (July) and 2020 (July). ...

    Abstract The anti-IL-5 biologic reslizumab for the treatment of severe eosinophilic asthma is administered intravenously. In the current study home administration of intravenous reslizumab was evaluated in 24 patients included between 2019 (July) and 2020 (July). This is the first study to show that intravenous reslizumab can be administered safely and successfully in an outpatient setting. Notably, not all patients prefer home administration and severe asthma patients may have different needs when it comes to choosing treatment at home or in the hospital.
    MeSH term(s) Anti-Asthmatic Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Asthma/drug therapy ; Humans ; Netherlands/epidemiology
    Chemical Substances Anti-Asthmatic Agents ; Antibodies, Monoclonal, Humanized ; reslizumab (35A26E427H)
    Language English
    Publishing date 2022-02-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2022.106776
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: ERS International Congress 2022: highlights from the Airway Diseases Assembly.

    Beech, Augusta / Portacci, Andrea / Herrero-Cortina, Beatrice / Mathioudakis, Alexander G / Gotera, Carolina / Uller, Lena / Ricciardolo, Fabio Luigi Massimo / Pobeha, Pavol / Snelgrove, Robert J / Braunstahl, Gert-Jan / Bossios, Apostolos / Usmani, Omar / Ananth, Sachin

    ERJ open research

    2023  Volume 9, Issue 3

    Abstract: The European Respiratory Society (ERS) celebrated the return of an in-person meeting in Barcelona, Spain, after 2 years of virtual congresses. The ERS Congress 2022 programme was replete with symposia, skills workshops and abstract presentations from all ...

    Abstract The European Respiratory Society (ERS) celebrated the return of an in-person meeting in Barcelona, Spain, after 2 years of virtual congresses. The ERS Congress 2022 programme was replete with symposia, skills workshops and abstract presentations from all 14 assemblies, encompassing over 3000 abstracts presented in the form of thematic poster discussion and oral presentations. In this article, highlights from the ERS Congress 2022 (including from thematic poster sessions, oral presentations and symposia from keynote speakers), presented by Assembly 5 (Airway diseases, asthma, COPD and chronic cough), are reviewed by Early Career Members and experts in the field, with the aim of presenting key recent findings in the field.
    Language English
    Publishing date 2023-05-22
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00034-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Pneumothorax in patients with prior or current COVID-19 pneumonia.

    Janssen, Matthijs L / van Manen, Mirjam J G / Cretier, Sander E / Braunstahl, Gert-Jan

    Respiratory medicine case reports

    2020  Volume 31, Page(s) 101187

    Abstract: As the number of COVID-19 cases emerge, new complications associated with the disease are recognized. We present three cases of spontaneous pneumothorax in patients with COVID-19. They show that a pneumothorax can occur during different phases of disease, ...

    Abstract As the number of COVID-19 cases emerge, new complications associated with the disease are recognized. We present three cases of spontaneous pneumothorax in patients with COVID-19. They show that a pneumothorax can occur during different phases of disease, in patients without a pulmonary disease history and is not necessarily associated to positive pressure ventilation or severity of COVID-19. Although the exact causative mechanisms remain unknown, this observation might imply that extensive alveolar destruction due to COVID-19 may lead to bulla formation resulting in subsequent pneumothorax.
    Keywords covid19
    Language English
    Publishing date 2020-08-13
    Publishing country England
    Document type Case Reports
    ZDB-ID 2666110-X
    ISSN 2213-0071
    ISSN 2213-0071
    DOI 10.1016/j.rmcr.2020.101187
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up.

    Witte, Jan / Singh, Harman / Turk, Yasemin / van Huisstede, Astrid / Birnie, Erwin / Hiemstra, Pieter / Kappen, Jasper / Braunstahl, Gert-Jan

    Allergy and asthma proceedings

    2023  Volume 44, Issue 3, Page(s) 165–170

    Abstract: Background: ...

    Abstract Background:
    MeSH term(s) Humans ; Follow-Up Studies ; Prospective Studies ; Quality of Life ; Bariatric Surgery ; Asthma ; Obesity ; Weight Gain ; Lung
    Language English
    Publishing date 2023-05-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1312445-6
    ISSN 1539-6304 ; 1088-5412
    ISSN (online) 1539-6304
    ISSN 1088-5412
    DOI 10.2500/aap.2023.44.230009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top